Amgen’s cancer-drug pipeline looks promising despite FDA setback, analysts say By: MarketWatch October 11, 2023 at 08:47 AM EDT Strong oncology, obesity, and cardiovascular drug candidates behind rating upgrade Read More >> Related Stocks: Amgen
